Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases

Bibliographic Details
Main Authors:	Cook, C. (Author), DiIorio, M. (Author), D'Silva, K.M (Author), Hsu, T.Y.-T (Author), Martin, L.W (Author), Patel, N.J (Author), Prisco, L. (Author), Sparks, J.A (Author), Todd, D. (Author), Vanni, K. (Author), Wallace, Z.S (Author), Zaccardelli, A. (Author)
Format:	Article
Language:	English
Published:	NLM (Medline) 2022
Subjects:	adult Adult antirheumatic agent Antirheumatic Agents autoimmune disease autoimmune diseases Autoimmune Diseases clinical trial COVID-19 COVID-19 Vaccines epidemiology female Female hospitalization Hospitalization human Humans male Male middle aged Middle Aged mortality multicenter study rheumatic disease Rheumatic Diseases SARS-CoV-2 therapy vaccination virology
Online Access:	View Fulltext in Publisher

View Fulltext in Publisher

Similar Items